Works matching IS 27686566 AND DT 2023 AND VI 2 AND IP 3
Results: 41
Issue Information.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 417, doi. 10.1002/jvc2.228
- Publication type:
- Article
Efficacy and safety of toning technique 1064 nm Q‐switched Nd:YAG laser in lichen planus pigmentosus associated with frontal fibrosing alopecia: An open‐label prospective study.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 643, doi. 10.1002/jvc2.209
- By:
- Publication type:
- Article
Implementing the NICE 2022 melanoma imaging guideline: At what cost?
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 634, doi. 10.1002/jvc2.207
- By:
- Publication type:
- Article
Disseminated lupus vulgaris without underlying active pulmonary tuberculosis.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 646, doi. 10.1002/jvc2.206
- By:
- Publication type:
- Article
Evaluation of the breaking points in the global care pathway of patients with atopic dermatitis.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 658, doi. 10.1002/jvc2.202
- By:
- Publication type:
- Article
Impact of the Covid‐19 pandemic on melanoma diagnosis: A retrospective study from the French clinical database of melanoma patients (RIC‐Mel).
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 638, doi. 10.1002/jvc2.201
- By:
- Publication type:
- Article
Biomarkers for disease progression identified in psoriasis patients: A pilot study.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 502, doi. 10.1002/jvc2.196
- By:
- Publication type:
- Article
A slowly growing, highly vascularized papule in a 4‐year‐old girl.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 666, doi. 10.1002/jvc2.193
- By:
- Publication type:
- Article
Effect of abrocitinib and dupilumab on eosinophil levels in patients with moderate‐to‐severe atopic dermatitis.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 518, doi. 10.1002/jvc2.192
- By:
- Publication type:
- Article
HSP90: A potential drug target in inflammatory skin diseases.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 450, doi. 10.1002/jvc2.191
- By:
- Publication type:
- Article
Efficacy of baricitinib 4 mg in patients with moderate‐to‐severe atopic dermatitis previously treated with systemic therapy.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 583, doi. 10.1002/jvc2.187
- By:
- Publication type:
- Article
Primary cutaneous follicle centre lymphoma with secondary systemic evolution.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 625, doi. 10.1002/jvc2.186
- By:
- Publication type:
- Article
Long‐term secukinumab efficacy and safety in bio‐naïve patients with moderate‐to‐severe cutaneous psoriasis: A real‐world retrospective noninterventional multicentric experience (128 patients).
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 576, doi. 10.1002/jvc2.185
- By:
- Publication type:
- Article
Excellent response to adalimumab in a patient with Papillon–Lefèvre syndrome: A case report.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 621, doi. 10.1002/jvc2.184
- By:
- Publication type:
- Article
Immunisation status during biologic therapy for hidradenitis suppurativa and psoriasis.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 549, doi. 10.1002/jvc2.182
- By:
- Publication type:
- Article
Papular interstitial elastolytic giant cell granuloma concomitant with lichen amyloidosus in a type II diabetes patient.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 612, doi. 10.1002/jvc2.180
- By:
- Publication type:
- Article
Observational 24‐week study to assess clinical response to upadacitinib posttrial in patients with moderate‐to‐severe atopic dermatitis.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 571, doi. 10.1002/jvc2.179
- By:
- Publication type:
- Article
Artificial intelligence—An opportunity to optimise the care of acneic patients.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 631, doi. 10.1002/jvc2.177
- By:
- Publication type:
- Article
Clinical characteristics of palmoplantar discoid lupus erythematosus: A multicenter retrospective review of 43 patients.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 566, doi. 10.1002/jvc2.176
- By:
- Publication type:
- Article
Real‐world drug survival of Brodalumab, in patients with psoriasis switched from Ixekizumab: Results of a single centre retrospective study (BroSwitch).
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 510, doi. 10.1002/jvc2.173
- By:
- Publication type:
- Article
Reactive infectious mucocutaneous eruption secondary to SARS‐CoV‐2 and influenza A coinfection with varicella zoster virus reactivation.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 617, doi. 10.1002/jvc2.172
- By:
- Publication type:
- Article
Reducing the treatment burden of keratinocyte cancers requiring referral to plastic surgery: Lessons from lockdown.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 553, doi. 10.1002/jvc2.171
- By:
- Publication type:
- Article
Assessing the burden of patients with psoriasis through the concept of cumulative life course impairment: A narrative literature review.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 423, doi. 10.1002/jvc2.170
- By:
- Publication type:
- Article
Collaboration in the management of psoriasis and psoriatic arthritis: A survey of joint working in UK clinical practice.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 559, doi. 10.1002/jvc2.169
- By:
- Publication type:
- Article
A patient with a papulo‐nodular lesion on the shoulder.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 662, doi. 10.1002/jvc2.168
- By:
- Publication type:
- Article
Severe cutaneous scleromyxedema treated by lenalidomide.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 608, doi. 10.1002/jvc2.159
- By:
- Publication type:
- Article
Acrodermatitis continua of Hallopeau with psoriatic arthritis treated with biologics and apremilast.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 601, doi. 10.1002/jvc2.157
- By:
- Publication type:
- Article
Apremilast treatment of plaque psoriasis (PsO) after systemic therapy in Spanish clinical practice: Data from the APPROPRIATE study.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 488, doi. 10.1002/jvc2.155
- By:
- Publication type:
- Article
A systematic review of isotretinoin dosing in acne vulgaris.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 432, doi. 10.1002/jvc2.154
- By:
- Publication type:
- Article
Generalized eruptive clear cell acanthomas.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 605, doi. 10.1002/jvc2.152
- By:
- Publication type:
- Article
Reduction in hospitalisations with dupilumab in Japanese adults with atopic dermatitis in a real‐world setting.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 543, doi. 10.1002/jvc2.151
- By:
- Publication type:
- Article
Dramatic deterioration or new‐onset dipeptidyl peptidase‐4 inhibitor‐associated bullous pemphigoid after COVID‐19 vaccination: A possible manifestation of immune reconstitution inflammatory syndrome.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 479, doi. 10.1002/jvc2.150
- By:
- Publication type:
- Article
Prevalence of feelings of stigma and coping strategies among patients with Hidradenitis suppurativa in France.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 629, doi. 10.1002/jvc2.147
- By:
- Publication type:
- Article
Atypical presentation of Monkeypox virus infection.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 598, doi. 10.1002/jvc2.146
- By:
- Publication type:
- Article
Severe lichenoid eruption due to concomitant medications following nivolumab administration.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 594, doi. 10.1002/jvc2.143
- By:
- Publication type:
- Article
A real‐world retrospective observational study exploring resource use for secondary care management of moderate‐to‐severe atopic dermatitis in children and adolescents at a single site in Ireland.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 465, doi. 10.1002/jvc2.142
- By:
- Publication type:
- Article
Physical activity and mental health among patients with atopic dermatitis or chronic spontaneous urticaria: A cross‐sectional study.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 648, doi. 10.1002/jvc2.140
- By:
- Publication type:
- Article
High frequency of cutaneous eruptions within the first year after allogeneic hematopoietic stem cell transplantation.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 456, doi. 10.1002/jvc2.125
- By:
- Publication type:
- Article
The association of hidradenitis suppurativa with obstructive sleep apnea: A cross‐sectional study using the All of Us database.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 537, doi. 10.1002/jvc2.118
- By:
- Publication type:
- Article
Focal vascular occlusion: A link between livedoid vasculopathy and cutaneous arteritis?
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 531, doi. 10.1002/jvc2.115
- By:
- Publication type:
- Article
Recalcitrant prurigo nodularis after COVID‐19 vaccination and successfully treated by dupilumab.
- Published in:
- JEADV Clinical Practice, 2023, v. 2, n. 3, p. 590, doi. 10.1002/jvc2.106
- By:
- Publication type:
- Article